Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Population-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Time.

Journal of the National Comprehensive Cancer Network : JNCCN - 1 Jun 2016

Lynce Filipa, Isaacs Claudine

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Ovariectomy

Source

Open in PubMed Open full text

Identifiers

PMID: 27283172
DOI: 10.6004/jnccn.2016.0081
PMCID: PMC5987769

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Population-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Time.PMID 27283172Read ↗

Population-based BRCA1/BRCA2 screening in Ashkenazi Jews: a call for evidence.Semantic proximity Read ↗

Clinical implications of BRCA1 genetic testing for Ashkenazi-Jewish women.Semantic proximity Read ↗

Carrier screening panels for Ashkenazi Jews: Is more better?Semantic proximity Read ↗

Genetic screening for gynecological cancer: where are we heading?Semantic proximity Read ↗

Population Based Testing for Primary Prevention: A Systematic ReviewSemantic proximity Read ↗

Population Screening for Inherited Predisposition to Breast and Ovarian Cancer.Semantic proximity Read ↗

Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.Semantic proximity Read ↗

Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry.Semantic proximity Read ↗

Identifying Ashkenazi Jewish <i>BRCA1/2</i> founder variants in individuals who do not self-report Jewish ancestrySemantic proximity Read ↗

A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testingSemantic proximity Read ↗

Experiences from a pilot program bringing BRCA1/2 genetic screening to theUS Ashkenazi Jewish population.Semantic proximity Read ↗

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.